Page last updated: 2024-11-03

pyrimethamine and Optic Nerve Diseases

pyrimethamine has been researched along with Optic Nerve Diseases in 2 studies

Maloprim: contains above 2 cpds

Optic Nerve Diseases: Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banta, JT1
Davis, JL1
Lam, BL1
Lee, MW1
Fong, KS1
Hsu, LY1
Lim, WK1

Other Studies

2 other studies available for pyrimethamine and Optic Nerve Diseases

ArticleYear
Presumed toxoplasmosic anterior optic neuropathy.
    Ocular immunology and inflammation, 2002, Volume: 10, Issue:3

    Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male

2002
Optic nerve toxoplasmosis and orbital inflammation as initial presentation of AIDS.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:11

    Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Blepharitis; CD4 Lymphocyte Count; Co

2006